BEF, Author at The Boomer Esiason Foundation

March 19, 2019

Axcan has completed its acquisition of Eurand N.V., a global specialty pharmaceutical company with operating units in the United States and Europe. In a February 11 letter, Axcan President and CEO Frank Verwiel explained how the merger will affect its customers: Dear Customer: We are pleased to...

Cystic Fibrosis Gene Typo is a Double Whammy

by BEF

CF News, Research

March 19, 2019

An imbalance of salt and water in patients with cystic fibrosis makes their lungs clog up with sticky mucus that is prone to infection. The cause of the offending imbalance is a well-known genetic error, one that blocks the molecular expressway for tiny chloride ions...

Impaired Metabolism in CF Lung Epithelial Cells Revealed by Metabolic Analysis

by BEF

CF News, Research

March 19, 2019

Note from BEF: The following Metabolon press release details a newly published research paper. The paper's findings "reveal novel metabolic abnormalities associated with the CF pathological process and identify a panel of potential biomarkers for therapeutic development using this model system," according to Metabolon. The...

Growth Defects in CF May Start Before Birth, Study Finds

by BEF

CF News, Research

March 19, 2019

A new study using a pig model of cystic fibrosis (CF) suggests that low levels of a growth promoting hormone at or before birth may contribute to growth defects in patients with CF. The study, led by University of Iowa researchers and published online the week...

Human Growth Hormone Shows Promise in Treating Cystic Fibrosis Symptoms

by BEF

CF News, Research

March 19, 2019

Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). Cystic fibrosis...

Bacteria Identified as New Foe for CF Patients

by BEF

CF News, Research

March 19, 2019

A new study links flare-ups of cystic fibrosis to a chronic bacterial infection, a finding that could give physicians new insight into the disease and offer a new target for medication. The germ in question is called Stenotrophomonas maltophilia. "Our study showed that chronic infection with S....

Researchers: Vitamin D May Treat, Prevent Allergic Reaction to Mold in CF Patients

by BEF

CF News, Research

March 19, 2019

Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, according to researchers from Children's Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of...

University of Texas Researcher Receives $2.1 Million Grant to Focus on Drug Delivery to Lungs

by BEF

CF News, Research

March 19, 2019

A University of Texas at Austin College of Pharmacy researcher has received a $2.1 million grant to develop new techniques for drug delivery to the lungs, helping in the fight against such lung diseases as cystic fibrosis. Dr. Hugh Smyth, assistant professor of pharmaceutics, was awarded...

Luminex Announces Commercial Launch of New CF Genetic Screening Test

by BEF

CF News, Research

March 19, 2019

Luminex Corporation, the worldwide leader in multiplexed solutions, announced the full commercial launch of its xTAG® Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of...

Researchers Still Expect Genetic Mapping Project Will Lead to New Drugs

by BEF

CF News, Research

March 19, 2019

NORTH WALES, PENN. -- At Merck's ''automated biotechnology facility'' here, robot arms adapted from automobile factories deftly shuttle plates containing human cells. Assisted by the robots and other complex machinery, scientists are studying what happens to the cells as each of the roughly 22,000 human genes...

Author: BEF

Axcan Pharma CEO Explains Impact of Axcan-Eurand Merger

Cystic Fibrosis Gene Typo is a Double Whammy

Impaired Metabolism in CF Lung Epithelial Cells Revealed by Metabolic Analysis

Growth Defects in CF May Start Before Birth, Study Finds

Human Growth Hormone Shows Promise in Treating Cystic Fibrosis Symptoms

Bacteria Identified as New Foe for CF Patients

Researchers: Vitamin D May Treat, Prevent Allergic Reaction to Mold in CF Patients

University of Texas Researcher Receives $2.1 Million Grant to Focus on Drug Delivery to Lungs

Luminex Announces Commercial Launch of New CF Genetic Screening Test

Researchers Still Expect Genetic Mapping Project Will Lead to New Drugs

Never miss an update. Subscribe to our emails!